Christopher A Voigt

This inventor holds 21 USPTO granted patents and 20 published patent applications and 1 EPO patent, primarily in Synthetic Biology. Top assignees: Massachusetts Institute of Technology, University of California, Harvard College. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher A Voigt. Retrieved from https://idiyas.com/inventor/christopher-a-voigt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 20)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 128(Granted Patents)

Location History:

San Francisco, CA (US) (2015)
Oakland, CA (US) (2014 - 2017)
Belmont, MA (US) (2016 - 2024)

Company Filing History:

14 out of 8,586

Massachusetts Institute of Technology

patents

9 out of 16,025

University of California

The Broad Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Melanin-Peptide Materials

Nitrogen Fixation

Synthetic Gene Clusters

DNA Optimization

Transcriptional Sensors

Biosynthetic Enzymes

Protease Modulation

Protein Interactions

Cell-Based Systems

Biological Production

Phytochromes

High-Throughput Assembly

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12360428 - Melanin-peptide-based photonic materials (2025-07-15),

2. 12281299 - Control of nitrogen fixation in rhizobia that associate with cereals (2025-04-21),

3. 12209245 - Synthetic gene clusters (2025-01-28),

4. 11976270 - Optimization of circular single stranded DNA using M13 phage (2024-05-07),

5. 11946162 - Directed evolution of synthetic gene cluster (2024-04-02),

6. 11898141 - High-throughput assembly of genetic elements (2024-02-13),

7. 11591604 - Gene expression in Bacteroides (2023-02-28),

8. 11479516 - Nitrogen fixation using refactored NIF clusters (2022-10-25),

9. 11441162 - Human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides (2022-09-13),

10. 11208664 - Transcriptional sensor for bile acids in bacteroides thetaiotaomicron (2021-12-28),

11. 11124498 - Compositions and methods for modulating protease activity (2021-09-21),

12. 10968446 - Directed evolution of synthetic gene cluster (2021-04-06),

13. 10882885 - Peptide-based synthetic molecules and silica nanostructures (2021-01-05),

14. 10662432 - Synthetic gene clusters (2020-05-26),

15. 10030320 - Anti-sigmas for programmable transcriptional regulation (2018-07-24),

Title: Innovations and Patents of Christopher A. Voigt

Introduction: Christopher A. Voigt is a notable inventor based in Oakland, California, who has made significant contributions to the field of synthetic biology. With a total of 19 patents to his name, Voigt has been at the forefront of research and innovation, particularly in the design and optimization of synthetic gene clusters. His work is not only influential in academic circles but also holds the potential for transformative applications in various industries.

Latest Patents: Among Voigt’s latest patents, he has developed methods for making synthetic gene clusters, which are critical for advancements in genetic engineering. Another notable patent focuses on the optimization of circular single-stranded DNA using M13 phage, where methodologies and compositions for producing single-stranded DNA (ssDNA) of uniform length are provided. These innovations highlight his dedication to enhancing the precision and efficacy of genetic manipulation techniques.

Career Highlights: Voigt has had an impressive academic and professional journey, working at renowned institutions such as the Massachusetts Institute of Technology and the University of California. His tenure at these research institutions has allowed him to engage in groundbreaking studies and collaborate with other leading scientists in the field.

Collaborations: Throughout his career, Christopher A. Voigt has collaborated with notable colleagues, including Dehua Zhao and Ethan Mirsky. These partnerships have enabled the cross-pollination of ideas and techniques, further advancing synthetic biology and its applications.

Conclusion: In summary, Christopher A. Voigt stands out as an innovative inventor whose work in synthetic biology continues to shape the landscape of genetic research. With a robust portfolio of patents and valuable collaborations, Voigt demonstrates the impact of inventive thinking on modern science and technology. His contributions are paving the way for future breakthroughs in synthetic gene design and optimization.

Profile summary based on public USPTO records.